Novozymes As B Stock Analysis

Novozymes Pink Sheet Analysis Notes

About 42.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 3rd of March 2023. Novozymes AS B had 5:1 split on the 28th of November 2011. Novozymes AS produces and sells industrial enzymes, microorganisms, and probiotics in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark. NOVOZYMES is traded on OTC Exchange in the United States.The quote for Novozymes AS B is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Novozymes AS B contact Ester Baiget at 45 44 46 00 00 or learn more at https://www.novozymes.com.

Novozymes Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 13.95 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Novozymes's market, we take the total number of its shares issued and multiply it by Novozymes's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Novozymes Profitablity

The company has Profit Margin (PM) of 0.21 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.26 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.26.

Technical Drivers

As of the 30th of April, Novozymes secures the Downside Deviation of 2.2, risk adjusted performance of 0.0183, and Mean Deviation of 1.39. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Novozymes AS B, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have collected data for nineteen technical drivers for Novozymes, which can be compared to its peers in the industry. Please verify Novozymes AS B jensen alpha and downside variance to decide if Novozymes AS B is priced some-what accurately, providing market reflects its recent price of 55.89 per share. Given that Novozymes AS B has jensen alpha of 0.0075, we recommend you to check Novozymes's last-minute market performance to make sure the company can sustain itself at a future point.

Novozymes AS B Price Movement Analysis

Novozymes Predictive Daily Indicators

Novozymes Forecast Models

Novozymes' time-series forecasting models are one of many Novozymes' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novozymes' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Novozymes prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Novozymes shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Novozymes. By using and applying Novozymes Pink Sheet analysis, traders can create a robust methodology for identifying Novozymes entry and exit points for their positions.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novozymes AS B. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

When running Novozymes' price analysis, check to measure Novozymes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novozymes is operating at the current time. Most of Novozymes' value examination focuses on studying past and present price action to predict the probability of Novozymes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novozymes' price. Additionally, you may evaluate how the addition of Novozymes to your portfolios can decrease your overall portfolio volatility.